StocksCo-Diagnostics IncCODX

CODX

Co-Diagnostics Inc

3.02 0.15 (5.23%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
2.99
B
3.02

Overview

Prev Close3.02
Day's Range 2.76 - 3.02
52 Week Range 2.76 - 10.87
Average Volume (3m)662.41K
1-Year Return-70.16%
Beta0.0456
Market Cap102.02M
P/E Ratio3.4
Revenue78.22M
EPS0.8876
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.711/04/202227/06/202206/09/20223.004.005.006.007.00
Chart times in UTC
Industry Biotechnology
CEO Dwight Howard Egan
Employees 101

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Co-Diagnostics Inc's revenues increased by 31.30% and amounted to 97.89M. Net income decreased by 13.70% to 36.66M. Net assets increased by 101.62% to 134.48M and EPS decreased from 1.52 to 1.23.
CODX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
86.11%
Net Profit Margin
-21,865.94%
Operating Margin
38.05%
Return On Investment
29.18%
09/21
12/21
03/22
06/22
Total Revenue
30.1M
20.4M
22.7M
5.02M
Gross Profit
26.7M
17.81M
19.17M
3.68M
Operating Income
13.63M
10.46M
9.82M
-4.15M
Net Income
11.48M
7.5M
11.71M
-2.69M